FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - BOERSE MUENCHEN 03:45:19 2024-07-12 pm EDT | ||
| 10.01 EUR | -5.74% |
|
| Current month | -2.15% | ||
| 1 month | -2.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 10.01 | -5.74% |
| 24-07-11 | 10.62 | +3.81% |
| 24-07-10 | 10.23 | +2.20% |
| 24-07-09 | 10.01 | +0.60% |
| 24-07-08 | 9.95 | +1.84% |
Real-time BOERSE MUENCHEN
Last update July 12, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BU |
| ISIN | DE000HD36BU4 |
| Date issued | 2024-02-28 |
| Strike | 118.4 $ |
| Maturity | Unlimited |
| Parity | 10.54 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.92 € |
|---|---|
| Lowest since issue | 7.36 € |
| Spread | 0.01 € |
| Spread % | 0.10% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
230.1
USD
Average target price
281.3
USD
Spread / Average Target
+22.27%
- Stock Market
- Certificates
- Certificat
